These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. A systematic review of risk communication in clinical trials: How does it influence decisions to participate and what are the best methods to improve understanding in a trial context? Coyle M; Gillies K PLoS One; 2020; 15(11):e0242239. PubMed ID: 33196663 [TBL] [Abstract][Full Text] [Related]
43. Supporting positive experiences and sustained participation in clinical trials: looking beyond information provision. Gillies K; Entwistle VA J Med Ethics; 2012 Dec; 38(12):751-6. PubMed ID: 22875981 [TBL] [Abstract][Full Text] [Related]
44. Making a decision about trial participation: the feasibility of measuring deliberation during the informed consent process for clinical trials. Gillies K; Elwyn G; Cook J Trials; 2014 Jul; 15():307. PubMed ID: 25073967 [TBL] [Abstract][Full Text] [Related]
46. A randomised controlled trial evaluating the utility of a patient Decision Aid to improve clinical trial (RAVES 08.03) related decision-making. Sundaresan P; Ager B; Turner S; Costa D; Kneebone A; Pearse M; Woo H; Tesson S; Juraskova I; Butow P Radiother Oncol; 2017 Oct; 125(1):124-129. PubMed ID: 28844330 [TBL] [Abstract][Full Text] [Related]
47. Interventions to improve patient understanding of cancer clinical trial participation: a systematic review. Kao CY; Aranda S; Krishnasamy M; Hamilton B Eur J Cancer Care (Engl); 2017 Mar; 26(2):. PubMed ID: 26786388 [TBL] [Abstract][Full Text] [Related]
48. Using theory and user-centered design in digital health: The development of the mychoice communication tool to prepare patients and improve informed decision making regarding clinical trial participation. Fleisher L; Bass SB; Shwarz M; Washington A; Nicholson A; Alhajji M; Geynisman DM; Maurer L; Greener J; Kenny C Psychooncology; 2020 Jan; 29(1):114-122. PubMed ID: 31654442 [TBL] [Abstract][Full Text] [Related]
49. Refusing the information paradigm: informed consent, medical research, and patient participation. Felt U; Bister MD; Strassnig M; Wagner U Health (London); 2009 Jan; 13(1):87-106. PubMed ID: 19103717 [TBL] [Abstract][Full Text] [Related]
50. Decision making in prostate cancer screening using decision aids vs usual care: a randomized clinical trial. Taylor KL; Williams RM; Davis K; Luta G; Penek S; Barry S; Kelly S; Tomko C; Schwartz M; Krist AH; Woolf SH; Fishman MB; Cole C; Miller E JAMA Intern Med; 2013 Oct; 173(18):1704-12. PubMed ID: 23896732 [TBL] [Abstract][Full Text] [Related]
51. Meeting patients' information needs beyond the year 2000. Tattersall MH; Butow PN; Ellis PM Support Care Cancer; 1997 Mar; 5(2):85-9. PubMed ID: 9069605 [TBL] [Abstract][Full Text] [Related]
52. Understanding the decisions of cancer clinical trial participants to enter research studies: factors associated with informed consent, patient satisfaction, and decisional regret. Stryker JE; Wray RJ; Emmons KM; Winer E; Demetri G Patient Educ Couns; 2006 Oct; 63(1-2):104-9. PubMed ID: 16242898 [TBL] [Abstract][Full Text] [Related]
53. The Attitude of Patients from a Romanian Tertiary Cardiology Center as Regards Participation in Biomarker-Based Clinical Trials - Survey Methodology. Mihaela Micheu M; Udrea OM; Octavia Popa M; Rusu I; Gheorghe-Fronea O; Scafa-Udriste A; Dorobantu M J Med Life; 2018; 11(4):320-327. PubMed ID: 30894889 [TBL] [Abstract][Full Text] [Related]
54. Gatekeeping in cancer clinical trials in Canada: The ethics of recruiting the "ideal" patient. Bell JAH; Kelly MT; Gelmon K; Chi K; Ho A; Rodney P; Balneaves LG Cancer Med; 2020 Jun; 9(12):4107-4113. PubMed ID: 32314549 [TBL] [Abstract][Full Text] [Related]
55. Interventions to increase patient and family involvement in escalation of care for acute life-threatening illness in community health and hospital settings. Mackintosh NJ; Davis RE; Easter A; Rayment-Jones H; Sevdalis N; Wilson S; Adams M; Sandall J Cochrane Database Syst Rev; 2020 Dec; 12(12):CD012829. PubMed ID: 33285618 [TBL] [Abstract][Full Text] [Related]
56. Informed consent for phase I studies: evaluation of quantity and quality of information provided to patients. Tomamichel M; Sessa C; Herzig S; de Jong J; Pagani O; Willems Y; Cavalli F Ann Oncol; 1995 Apr; 6(4):363-9. PubMed ID: 7619751 [TBL] [Abstract][Full Text] [Related]
57. Research information knowledge, perceived adequacy, and understanding in cancer clinical trial participants. Biedrzycki BA Oncol Nurs Forum; 2011 Jul; 38(4):E291-6. PubMed ID: 21708524 [TBL] [Abstract][Full Text] [Related]
58. Decision aids for people facing health treatment or screening decisions. O'Connor AM; Stacey D; Entwistle V; Llewellyn-Thomas H; Rovner D; Holmes-Rovner M; Tait V; Tetroe J; Fiset V; Barry M; Jones J Cochrane Database Syst Rev; 2003; (2):CD001431. PubMed ID: 12804407 [TBL] [Abstract][Full Text] [Related]
59. Reducing research waste by promoting informed responses to invitations to participate in clinical trials. Gillies K; Chalmers I; Glasziou P; Elbourne D; Elliott J; Treweek S Trials; 2019 Oct; 20(1):613. PubMed ID: 31661029 [TBL] [Abstract][Full Text] [Related]
60. A qualitative systematic review of internal and external influences on shared decision-making in all health care settings. Truglio-Londrigan M; Slyer JT; Singleton JK; Worral P JBI Libr Syst Rev; 2012; 10(58):4633-4646. PubMed ID: 27820528 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]